VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASCO 2015 | Results of the phase 2 trial of daratumumab in multiple myeloma

Dr Joseph Mikhael, at ASCO 2015, discusses the results of the phase 2 study of daratumumab in patients with 3 or more lines of prior therapy, or double refractory multiple myeloma.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter